4AB:FRA
AbbVie Common Stock
262,80 €
arrow_upward
+0,27%(+0,70) 1D
11-ноя., 15:48:39 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
262,30 €
High
263,30 €
Low
260,10 €
Mkt. cap
513,14 млд
Avg. vol.
96,00
Volume
77,00
52-wk high
272,30 €
52-wk low
167,55 €
No. of employees
57 миң
Open
262,30 €
High
263,30 €
Low
260,10 €
Mkt. cap
513,14 млд
Avg. vol.
96,00
Volume
77,00
52-wk high
272,30 €
52-wk low
167,55 €
No. of employees
57 миң
News stories
From web sources and news partners
Kalkine
·
1 күн мурун
AbbVie (NYSE:ABBV) Expands Immunology Pipeline After Acquisition and Earnings Update
The Globe and Mail
·
2 күн мурун
Zacks Investment Ideas feature highlights: Moderna, AbbVie, Eli Lilly and Merck
Yahoo Finance
·
2 күн мурун
Is AbbVie Inc. (ABBV) the Best Healthcare Stock to Buy Following the 2026 Democratic Midterm Sweep?
WSJ
·
1 апта мурун
AbbVie Revenue Rises on Strength in Immunology, Neuroscience
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 миң
Founded2012-ж., 10-апр.
HeadquartersСевер Чикаго, Иллинойс, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websiteabbvie.com